Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P33
Within normal range
vs 2Y Ago
-2.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -154.29% |
| 2024 | 195.88% |
| 2023 | 52.63% |
| 2022 | -55.76% |
| 2021 | -157.51% |
| 2020 | -273.45% |
| 2019 | 0.00% |